FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1359-1361 March 25, 2004 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by McConnell, J. D. PubMed Citation

To the Editor: In the United States, the incidence of breast cancer in men 65 years of age or older is 5.5 cases per 100,000 man-years.¹ The finding, reported by McConnell et al. (Dec. 18 issue),² that four men had breast cancer after treatment with finasteride alone or finasteride with doxazosin in a trial of the size and duration of the Medical Therapy of Prostatic Symptoms (MTOPS) study is unexpected.

From 1992 through December 2003, the Food and Drug Administration (FDA) received reports of 13 men in the United States in whom breast cancer developed during finasteride therapy (9 men) . . . [Full Text of this Article]

This article has been cited by other articles:

• Verhamme, K. M C, Sturkenboom, M. C J M (2007). Mortality in men admitted to hospital with acute urinary retention. BMJ 335: 1164-1165 [Full Text]  
• Zerbini, L. F., Czibere, A., Wang, Y., Correa, R. G., Otu, H., Joseph, M., Takayasu, Y., Silver, M., Gu, X., Ruchusatsawat, K., Li, L., Sarkar, D., Zhou, J.-R., Fisher, P. B., Libermann, T. A. (2006). A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis and Growth Arrest of Cancer Cells. Cancer Res. 66: 11922-11931 [Abstract] [Full Text]